Upfront Immunotherapy for Metastatic Kidney Cancer
0 Görünümler
• 06/26/23
0
0
gömmek
administrator
Aboneler
Panelists Robert A. Figlin, MD, and Eric Jonasch, MD, provide insight on the implications of frontline trials for immunotherapy and cabozantinib use, and the rationale for combination trials for metastatic kidney cancer.
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar